Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 465 of 5804
-
New pill could ease psoriatic arthritis without biologics
Disease control Recruiting nowPsoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO). The main aim of the study is to know how well zasocitinib (TAK-279) works in participants with active PsA who have not previously been treated with bi…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug YA-101 aims to slow rare brain disease
Disease control Recruiting nowThis is a Phase 2, double-blind, placebo-controlled, multi-center, Phase II, dose escalation study to evaluate the safety, tolerability, pharmacokinetics and efficacy of Ya-101 in subjects with multiple system atrophy.
Phase: PHASE2 • Sponsor: Dasher Neuroscience Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can longer therapy and brain scans predict and prevent suicide in veterans?
Disease control Recruiting nowThe suicide rate among active duty service members and Veterans increased substantially following the onset of post-9/11 conflicts in Iraq and Afghanistan. Accordingly, Veteran suicide prevention has been identified as a national healthcare and research priority. The investigator…
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Which drug cuts C-Section bleeding best? tranexamic acid vs misoprostol put to the test
Disease control CompletedBrief Summary The goal of this clinical trial is to compare two medicines, intravenous tranexamic acid and rectal misoprostol, for reducing blood loss in women undergoing cesarean section. The study will also compare how much hemoglobin (a measure of blood loss) decreases after …
Phase: PHASE4 • Sponsor: Medicare Hospital (Pvt) Limited • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Spinal implant sparks hope for movement recovery in paralysis patients
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and effectiveness of Epidural Electrical Stimulation (EES) in motor and sensory function Reconstruction in chronic spinal cord injury (SCI) patients classified as ASIA B-D. The main questions it aims to answer are: Does E…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy may help women with early breast cancer avoid mastectomy
Disease control ENROLLING_BY_INVITATIONThis is a phase II single-center single-arm clinical study designed to analyze the efficacy and safety of trastuzumab combined with taxane neoadjuvant therapy for HER2-positive breast carcinoma in situ (or with invasive carcinoma).
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could freezing tumors plus chemo slow prostate cancer spread?
Disease control Recruiting nowThe goal of this clinical trial is to explore whether androgen deprivation therapy combined with novel androgen receptor inhibitors, prostate cryoablation, and metronomic cyclophosphamide is superior to the current treatment regimen of androgen deprivation therapy plus novel andr…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New combo therapy aims to shrink hard-to-treat liver tumors
Disease control Recruiting nowAt present, the first-line treatment for patients with advanced unresectable intrahepatic cholangiocarcinoma is mainly systemic treatment, but the improvement in efficacy is limited and is not enough to meet the current clinical treatment needs. Hepatic artery infusion chemothera…
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
AI coach for lung surgery recovery: could it cut complications?
Symptom relief Recruiting nowThis study is a multicenter, prospective, randomized controlled trial designed to evaluate the effectiveness and safety of a multimodal artificial intelligence (AI)-guided postoperative recovery management system in patients after lung cancer surgery. Eligible patients will be en…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New drug could supercharge radiation for brain metastases in breast cancer
Disease control Recruiting nowA prospective, multicenter, observational cohort study to evaluate the efficacy and safety of a novel anti-tumor drug as a radiosensitizer in patients with advanced breast cancer brain metastasis.
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can a diabetes drug protect kidneys in heart failure patients?
Disease control Recruiting nowEffects of Empagliflozin compared with placebo in cardiorenal syndrome type 1, evaluated by MAKE30.
Phase: PHASE2, PHASE3 • Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New trial tests if operating on Newborns' hearts within 28 days beats waiting months
Disease control Recruiting nowChild health serves as the foundation for overall public health, with neonatal mortality recognized globally as a comprehensive indicator of national health standards and societal advancement. The Healthy Children Action Improvement Plan (2021-2025) sets a national target to redu…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:49 UTC
-
Simple blood test could catch myeloma years earlier in High-Risk groups
Diagnosis Recruiting nowThe purpose of this study is to identify multiple myeloma in the precancerous MGUS stage in order to reduce the risk of delayed diagnosis of multiple myeloma, decrease morbidity related to multiple myeloma at progression, and improve long term outcomes.
Sponsor: Wake Forest University Health Sciences • Aim: Diagnosis
Last updated Jul 15, 2026 00:00 UTC
-
New drug aims to save Insulin-Making cells in type 1 diabetes
Disease control OngoingThis is a randomized, placebo-controlled, parallel group, multicenter, double-blind Phase 2a, 2-arm study. The goal of this Phase 2a study is to assess safety and efficacy of brivekimig in comparison to placebo to preserve β-cell function in participants with recently diagnosed …
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a Five-Day NSAID course curb opioid dependence after severe bone injuries?
Disease control Recruiting nowThe goal of this randomized clinical trial is to learn if the use of a low-dose nonsteroidal anti-inflammatory drug (NSAID), ketorolac, reduces the rate of chronic opioid use in orthopaedic trauma patients. The main questions this study aims to answer are: 1. Are patients who ar…
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New schizophrenia pill shows promise in major trial
Disease control Recruiting nowEvaluate the efficacy and safety of Ulotaront (SEP-363856) in acutely psychotic subjects with schizophrenia
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a Twice-Yearly shot help kids with rare high cholesterol?
Disease control Recruiting nowThis is a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in children (aged 2 to \<12 years) with homozygous familial hypercholesterolemia (HoFH) and elevated low density lipoprotein cholesterol (LDLC).
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a personalized video and phone call get more teens the HPV vaccine?
⭐️ VACCINE ⭐️ OngoingDevelop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the University of California, Davis Health Community Physician (UCDH CP) primary care practices using a randomized controlled…
Phase: NA • Sponsor: University of California, Davis • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 19, 2026 00:00 UTC
-
Electromagnetic fields join the fight against pancreatic cancer
Disease control Recruiting nowThe goal of this study is to learn if the combination of nab-paclitaxel, gemcitabine and an Amplitude-Modulated Radiofrequency Electromagnetic Fields device (Therabionic P1) is safe and effective for patients with adenocarcinoma of the pancreas.
Phase: PHASE2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New study aims to boost HIV prevention in black women facing violence
Prevention Recruiting nowU.S. epidemiological data indicates that Black women are a high-risk HIV disparity group, yet initiation of novel prevention strategies like pre-exposure prophylaxis (PrEP) among this group is stagnant. Socio-structural challenges like intimate partner violence and gendered racis…
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC